These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25963222)

  • 1. Contemporary cardiovascular device clinical trials (trends and patterns 2001 to 2012).
    Vaduganathan M; Tahhan AS; Greene SJ; Kelkar AA; Georgiopoulou VV; Kalogeropoulos AP; Fonarow GC; Gheorghiade M; Butler J
    Am J Cardiol; 2015 Jul; 116(2):307-12. PubMed ID: 25963222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in characteristics of cardiovascular clinical trials 2001-2012.
    Butler J; Tahhan AS; Georgiopoulou VV; Kelkar A; Lee M; Khan B; Peterson E; Fonarow GC; Kalogeropoulos AP; Gheorghiade M
    Am Heart J; 2015 Aug; 170(2):263-72. PubMed ID: 26299223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Heart Failure Clinical Trials From 2001-2012.
    Samman Tahhan A; Vaduganathan M; Kelkar A; Georgiopoulou VV; Kalogeropoulos AP; Greene SJ; Fonarow GC; Gheorghiade M; Butler J
    J Card Fail; 2016 Mar; 22(3):171-9. PubMed ID: 26106806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal Trends in Use of Composite End Points in Major Cardiovascular Randomized Clinical Trials in Prominent Medical Journals.
    Tan NS; Ali SH; Lebovic G; Mamdani M; Laupacis A; Yan AT
    Circ Cardiovasc Qual Outcomes; 2017 Oct; 10(10):. PubMed ID: 28954803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric cardiovascular safety: challenges in drug and device development and clinical application.
    Bates KE; Vetter VL; Li JS; Cummins S; Aguel F; Almond C; Dubin AM; Elia J; Finkle J; Hausner EA; Joseph F; Karkowsky AM; Killeen M; Lemacks J; Mathis L; McMahon AW; Pinnow E; Rodriguez I; Stockbridge NL; Stockwell M; Tassinari M; Krucoff MW
    Am Heart J; 2012 Oct; 164(4):481-92. PubMed ID: 23067905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premarket clinical evaluation of novel cardiovascular devices: quality analysis of premarket clinical studies submitted to the Food and Drug Administration 2000-2007.
    Kramer DB; Mallis E; Zuckerman BD; Zimmerman BA; Maisel WH
    Am J Ther; 2010; 17(1):2-7. PubMed ID: 20038828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current challenges for clinical trials of cardiovascular medical devices.
    Zannad F; Stough WG; Piña IL; Mehran R; Abraham WT; Anker SD; De Ferrari GM; Farb A; Geller NL; Kieval RS; Linde C; Redberg RF; Stein K; Vincent A; Woehrle H; Pocock SJ
    Int J Cardiol; 2014 Jul; 175(1):30-7. PubMed ID: 24861254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute.
    Harris DJ; Douglas PS
    N Engl J Med; 2000 Aug; 343(7):475-80. PubMed ID: 10944565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who refuses enrollment in cardiac clinical trials?
    Sen Biswas M; Newby LK; Bastian LA; Peterson ED; Sugarman J
    Clin Trials; 2007; 4(3):258-63. PubMed ID: 17715252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Consent for Clinical Trials in Cardiovascular Disease.
    Kerkhoff LA; Butler J; Kelkar AA; Shore S; Speight CD; Wall LK; Dickert NW
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27317350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International participation in cardiovascular randomized controlled trials sponsored by the National Heart, Lung, and Blood Institute.
    Kim ES; Carrigan TP; Menon V
    J Am Coll Cardiol; 2011 Aug; 58(7):671-6. PubMed ID: 21816301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of industry sponsorship to published outcomes in gastrointestinal clinical research.
    Brown A; Kraft D; Schmitz SM; Sharpless V; Martin C; Shah R; Shaheen NJ
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1445-51. PubMed ID: 17101295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality trials in cardiovascular medicine.
    Lewis JA
    Cardiology; 1994; 84(6):385-90. PubMed ID: 8062304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do current clinical trials meet society's needs?: a critical review of recent evidence.
    Pocock SJ; Gersh BJ
    J Am Coll Cardiol; 2014 Oct; 64(15):1615-28. PubMed ID: 25301467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Trial Educator program - a novel approach to accelerate enrollment in a phase III International Acute Coronary Syndrome Trial.
    Kendall B; Städeli R; Schegg B; Olbrich M; Chen E; Harmelin-Kadouri R; Aurup P; Schwab T; Hildemann SK
    Clin Trials; 2012 Jun; 9(3):358-66. PubMed ID: 22426648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low rate of sex-specific result reporting in cardiovascular trials.
    Blauwet LA; Hayes SN; McManus D; Redberg RF; Walsh MN
    Mayo Clin Proc; 2007 Feb; 82(2):166-70. PubMed ID: 17290722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in Utilization of Surrogate Endpoints in Contemporary Cardiovascular Clinical Trials.
    Patel RB; Vaduganathan M; Samman-Tahhan A; Kalogeropoulos AP; Georgiopoulou VV; Fonarow GC; Gheorghiade M; Butler J
    Am J Cardiol; 2016 Jun; 117(11):1845-50. PubMed ID: 27085935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular biomarkers and surrogate end points: key initiatives and clinical trial challenges.
    Heinonen TM; Aamer M; Marshall C; Black DM; Tardif JC
    Expert Rev Cardiovasc Ther; 2012 Aug; 10(8):989-94. PubMed ID: 23030288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Future of Clinical Trials in Cardiovascular Medicine.
    Solomon SD; Pfeffer MA
    Circulation; 2016 Jun; 133(25):2662-70. PubMed ID: 27324361
    [No Abstract]   [Full Text] [Related]  

  • 20. [Recent study results in cardiology].
    Stiefelhagen P
    Internist (Berl); 2005 Jan; 46(1):86-91. PubMed ID: 15602680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.